These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22260843)

  • 1. Mumps vaccine effectiveness against orchitis.
    Hahné S; Whelan J; van Binnendijk R; Swaan C; Fanoy E; Boot H; de Melker H
    Emerg Infect Dis; 2012 Jan; 18(1):191-3. PubMed ID: 22260843
    [No Abstract]   [Full Text] [Related]  

  • 2. Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006.
    Yung CF; Andrews N; Bukasa A; Brown KE; Ramsay M
    Emerg Infect Dis; 2011 Apr; 17(4):661-7; quiz 766. PubMed ID: 21470456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mumps outbreaks: Implementation of a third dose of mumps-containing vaccine.
    Berlin KJ; Hayney MS
    J Am Pharm Assoc (2003); 2018; 58(5):577-578. PubMed ID: 30190108
    [No Abstract]   [Full Text] [Related]  

  • 4. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
    Cohen C; White JM; Savage EJ; Glynn JR; Choi Y; Andrews N; Brown D; Ramsay ME
    Emerg Infect Dis; 2007 Jan; 13(1):12-7. PubMed ID: 17370510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany.
    Beleni AI; Borgmann S
    Int J Environ Res Public Health; 2018 Jul; 15(8):. PubMed ID: 30065192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of vaccination on measles, mumps, and rubella antibody titers in Japanese healthcare workers: An observational study.
    Ogawa T; Inoue T; Kasahara K; Konishi M; Mikasa K
    PLoS One; 2020; 15(3):e0230329. PubMed ID: 32208432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine compliance and the 2016 Arkansas mumps outbreak.
    Majumder MS; Nguyen CM; Cohn EL; Hswen Y; Mekaru SR; Brownstein JS
    Lancet Infect Dis; 2017 Apr; 17(4):361-362. PubMed ID: 28346168
    [No Abstract]   [Full Text] [Related]  

  • 10. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of Rubella vaccine in a rubella outbreak in Guangzhou city, China, 2014.
    Chang C; Mo X; Hu P; Liang W; Ma H; An Z; Liu J; Zheng H
    Vaccine; 2015 Jun; 33(28):3223-7. PubMed ID: 25989448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outbreak of measles in medical students and determination of immune status to measles-mumps-rubella viruses.
    Yalçin SS; Kanra G; Pehlivan T
    Int J Adolesc Med Health; 2006; 18(4):615-22. PubMed ID: 17340852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.
    Lam E; Rosen JB; Zucker JR
    Clin Microbiol Rev; 2020 Mar; 33(2):. PubMed ID: 32102901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.
    Carryn S; Feyssaguet M; Povey M; Di Paolo E
    Vaccine; 2019 Aug; 37(36):5323-5331. PubMed ID: 31345639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and spatial distribution of MMR vaccine coverage in Brazil during 2007-2017.
    Pacheco FC; França GVA; Elidio GA; Domingues CMAS; de Oliveira C; Guilhem DB
    Vaccine; 2019 May; 37(20):2651-2655. PubMed ID: 30987853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak report.
    Fields VS; Safi H; Waters C; Dillaha J; Capelle L; Riklon S; Wheeler JG; Haselow DT
    Lancet Infect Dis; 2019 Feb; 19(2):185-192. PubMed ID: 30635255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successes and challenges for preventing measles, mumps and rubella by vaccination.
    Bankamp B; Hickman C; Icenogle JP; Rota PA
    Curr Opin Virol; 2019 Feb; 34():110-116. PubMed ID: 30852425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low measles, mumps and rubella (MMR) vaccine uptake in hospital healthcare worker contacts following suspected mumps infection.
    Williams CJ; Liebowitz LD; Levene J; Nair P
    J Hosp Infect; 2010 Sep; 76(1):91-2. PubMed ID: 20542592
    [No Abstract]   [Full Text] [Related]  

  • 19. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines?
    Connell AR; Connell J; Leahy TR; Hassan J
    Front Immunol; 2020; 11():2089. PubMed ID: 33072071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.